ZhuZhou QianJin Pharmaceutical Co Ltd (600479 SHG) stock market data APIs

ZhuZhou QianJin Pharmaceutical Co.,Ltd engages in the production and sales of Chinese and Western medicines in China. The company offers traditional chinese medicine that cover areas, such as pelvic inflammatory disease, menstrual disorders, cervicitis, dysfunctional uterine bleeding, breast hyperplasia, postpartum blood and qi deficiency, and menopausal syndrome; chemical products that covers areas, including gynecology, cardiovascular system, endocrine system, liver and kidney diseases, oncology and immune system, antiviral, psychotropic, and tonic products; API; TCM derivatives; and hygienic products, such as gynaecological and baby nursing, and maternity pad/ maternity package. It is also involved in the provision of prepared slices of Chinese medicinal herbs; planting and sales of Chinese medicinal materials; sales of Class I and Class II medical devices, as well as food, wine, beverages, tea, bulk food, hygiene and disinfection products, cosmetics and hygiene products, disinfectants, health care products, agricultural products, daily necessities, and bee products; wholesale and retail of pharmaceuticals, movies, video screenings, video games, cold drinks, tobacco, alcohol, and non-staple foods; equity investment and investment consulting activities. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 and is headquartered in Zhuzhou, China.